1. Ashino, T., Sugiuchi, J., Uehara, J., Naito-Yamamoto, Y., Kenmotsu, S., Iwakura, Y., Shioda, S., Numazawa, S. and Yoshida, T. (2011): Auranofin protects against cocaine-induced hepatic injury through induction of heme oxygenase-1. J. Toxicol. Sci., 36, 635-643.
2. Atwood, B.K. and Mackie, K. (2010): CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol., 160, 467-479.
3. Badal, S. and Delgoda, R. (2014): Role of the modulation of CYP1A1 expression and activity in chemoprevention. J. Appl. Toxicol., 34, 743-753.
4. Burke, M.D. and Mayer, R.T. (1974): Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos., 2, 583-588.
5. Devane, W.A., Dysarz, F.A.3rd, Johnson, M.R., Melvin, L.S. and Howlett, A.C. (1988): Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.